VictoriaAJohnsonMD

PubMed

• 3 citations
  Antiretroviral Activity of AMD11070 (An Orally Administered CXCR4 Entry Inhibitor): Results of NIH/NIAID AIDS Clinical Trials Group Protocol A5210.
  Victoria A. Johnson, Yoninah S Cramer, Susan L. Rosenkranz, Stephen Becker, Karin L. Klingman, Beatrice Kallungal, Eoin Coakley, Edward P. Acosta, Gary Calandra, Micha...> ;AIDS Research and Human Retroviruses. 2019 Aug 1
• 2 citations
  Combination antiretroviral treatment for women previously treated only in pregnancy: week 24 results of AIDS clinical trials group protocol a5227.
  Mary A. Vogler, Laura M. Smeaton, Rodney L. Wright, Sandra W. Cardoso, Jorge Sanchez, Rosa Infante, Laura E Moran, Catherine Godfrey, Lisa M. Demeter, Victoria A. Johnson> ;Journal of Acquired Immune Deficiency Syndromes. 2014 Apr 15
• 87 citations
  Safety and Antiviral Activity of the HCV Entry Inhibitor ITX5061 in Treatment-Naive HCV-Infected Adults: A Randomized, Double-Blind, Phase 1b Study
  Mark S. Sulkowski, Minhee Kang, Roy M. Matining, David L. Wyles, Victoria A. Johnson, Gene D. Morse, Valerianna Amorosa, Debika Bhattacharya, Kristine Coughlin, Flossi...> ;The Journal of Infectious Diseases. 2014 Mar 1
• 4 citations
  Addition of Nitazoxanide to PEG-IFN and Ribavirin to Improve HCV Treatment Response in HIV-1 and HCV Genotype 1 Coinfected Persons Naïve to HCV Therapy: Results of the...
  Valerianna Amorosa, Anne F Luetkemeyer, Minhee Kang, Victoria A. Johnson, Triin Umbleja, David W. Haas, Suria Yesmin, Matthew C. Bardin, Raymond T. Chung, Beverly Alst...> ;Hiv Clinical Trials. 2013 Nov 1
• 1 citations
  Factors associated with remaining on initial randomized efavirenz-containing regimens.
  Marlene Smurzynski, Kunling Wu, Jeffrey T. Schouten, Judith J. Lok, Ronald J. Bosch, Babafemi Taiwo, Victoria A. Johnson, Ann C. Collier> ;AIDS. 2013 Jul 31
• 12 citations
  Risk of Vancomycin-induced Nephrotoxicity in the Population With Chronic Kidney Disease
  Bhupesh Panwar, Victoria A. Johnson, Mukesh Patel, Daniel F. Balkovetz> ;The American Journal of the Medical Sciences. 2013 May 1
• 37 citations
  Structural and photophysical properties of visible- and near-IR-emitting tris lanthanide(III) complexes formed with the enantiomers of N,N'-bis(1-phenylethyl)-2,6-pyri...
  KimNgan T. Hua, Jide Xu, Eliseo E. Quiroz, Sabrina Lopez, Andrew J. Ingram, Victoria Anne Johnson, Angela R. Tisch, Ana de Bettencourt-Dias, Daniel A. Straus, Gilles M...> ;Inorganic Chemistry. 2012 Jan 2
• 51 citations
  Macrocycles that inhibit the binding between heat shock protein 90 and TPR-containing proteins
  Veronica C. Ardi, Leslie D. Alexander, Victoria A. Johnson, Shelli R. McAlpine> ;ACS Chemical Biology. 2011 Dec 16
• 31 citations
  Macrocyclic Inhibitors of Hsp90
  Victoria A. Johnson, Erinprit K. Singh, Lidia A. Nazarova, Leslie D. Alexander, Shelli R. McAlpine> ;Current Topics in Medicinal Chemistry. 2010 Sep 30
• 53 citations
  Design and synthesis of Hsp90 Inhibitors: exploring the SAR of Sansalvamide A derivatives
  Robert P. Sellers, Leslie D. Alexander, Victoria A. Johnson, Chun-Chieh Lin, Jeremiah Savage, Ricardo Corral, Jason A. Moss, Tim S. Slugocki, Erinprit K. Singh, Melind...> ;Bioorganic & Medicinal Chemistry. 2010 Sep 15
• 10 citations
  Cost ramifications of increased reporting of detectable plasma HIV-1 RNA levels by the Roche COBAS AmpliPrep/COBAS TaqMan HIV-1 version 1.0 viral load test.
  James H. Willig, Christa R. Nevin, James L. Raper, Michael S. Saag, Michael J. Mugavero, Amanda L. Willig, Jeffrey H Burkhardt, Joseph E. Schumacher, Victoria A. Johnson> ;Journal of Acquired Immune Deficiency Syndromes. 2010 Aug 1
• 156 citations
  Pre-existing Minority Drug-Resistant HIV-1 Variants, Adherence, and Risk of Antiretroviral Treatment Failure
  Roger Paredes, Christina M. Lalama, Heather J. Ribaudo, Bruce R. Schackman, Cecilia M. Shikuma, Francoise Giguel, William A. Meyer, Victoria A. Johnson, Susan A. Fiscu...> ;The Journal of Infectious Diseases. 2010 Mar 1
• 11 citations
  Evaluation of di-sansalvamide A derivatives: synthesis, structure-activity relationship, and mechanism of action.
  Leslie D. Alexander, Robert P. Sellers, Melinda Davis, Veronica C. Ardi, Victoria A. Johnson, Robert C. Vasko, Shelli R. McAlpine> ;Journal of Medicinal Chemistry. 2009 Dec 24
• 238 citations
  Abacavir-lamivudine versus tenofovir-emtricitabine for initial HIV-1 therapy.
  Paul E. Sax, Camlin Tierney, Ann C. Collier, Margaret A. Fischl, Katie R. Mollan, Lynne Peeples, Catherine Godfrey, Nasreen C. Jahed, Laurie Myers, David Katzenstein, ...> ;The New England Journal of Medicine. 2009 Dec 16
• 32 citations
  A comprehensive study of Sansalvamide A derivatives: The structure-activity relationships of 78 derivatives in two pancreatic cancer cell lines.
  Po-Shen Pan, Robert C. Vasko, Stephanie A. Lapera, Victoria A. Johnson, Robert P. Sellers, Chun-Chieh Lin, Chung-Mao Pan, Melinda Davis, Veronica C. Ardi, Shelli R. Mc...> ;Bioorganic & Medicinal Chemistry. 2009 Aug 15
• 5 citations
  Novel methodology for antiretroviral quantitation in the female genital tract.
  Chantelle Bennetto-Hood, Victoria A. Johnson, Jennifer R. King, Craig J. Hoesley, Edward P. Acosta> ;Hiv Clinical Trials. 2009 May 1
• 6 citations
  Replication capacity in relation to immunologic and virologic outcomes in HIV-1-infected treatment-naive subjects.
  Gail Skowron, John Spritzler, Jodi Weidler, Gregory K. Robbins, Victoria A. Johnson, Ellen S. Chan, David M. Asmuth, Rajesh T. Gandhi, Yolanda Lie, Michael Bates, Rich...> ;Journal of Acquired Immune Deficiency Syndromes. 2009 Mar 1
• Mass fatality planning for pandemic influenza: a planning model from a seven-county region in Kentucky.
  Victoria A. Johnson> ;Journal of Public Health Management and Practice. 2009 Mar 1
• 1166 citations
  Update of the Drug Resistance Mutations in HIV-1.
  Johnson, V. A., Brun-Vezinet, F., Clotet, B., Gunthard, H. F., Kuritzkes, D. R., Pillay, D., Schapiro, J. M., Richman, D. D.> ;Topics in HIV medicine : a publication of the International AIDS Society, USA. 2008 Dec 25
• Antiretroviral drug resistance testing in adult HIV-1 infection: 2008 recommendations of an International AIDS Society-USA panel.
  Hirsch, M. S., Günthard, H. F., Schapiro, J. M., Brun-Vézinet, F., Clotet, B., Hammer, S. M., Johnson, V. A., Kuritzkes, D. R., Mellors, J. W., Pillay, D., Yeni, P. G....> ;Clin Infect Dis. 2008 Jul 15
• 21 citations
  Treatment response in acute/early infection versus advanced AIDS: equivalent first and second phases of HIV RNA decline.
  J. Michael Kilby, Ha Youn Lee, J. Darren Hazelwood, Anju Bansal, R. Patterson Bucy, Michael S. Saag, George M. Shaw, Edward P. Acosta, Victoria A. Johnson, Alan S. Per...> ;AIDS. 2008 May 11
• Update of the drug resistance mutations in HIV-1: Spring 2008.
  Johnson, V. A., Brun-Vezinet, F., Clotet, B., Günthard, H. F., Kuritzkes, D. R., Pillay, D., Schapiro, J. M., Richman, D. D.> ;Topics in HIV medicine : a publication of the International AIDS Society, USA. 2008 Apr 29
• 132 citations
  Preexisting Resistance to Nonnucleoside Reverse-Transcriptase Inhibitors Predicts Virologic Failure of an Efavirenz-Based Regimen in Treatment-Naive HIV-1–Infected Sub...
  Daniel R. Kuritzkes, Christina M. Lalama, Heather J. Ribaudo, Michelle Marcial, William A. Meyer, Cecilia M. Shikuma, Victoria A. Johnson, Susan A. Fiscus, Richard T. ...> ;The Journal of Infectious Diseases. 2008 Mar 15
• 17 citations
  Intracellular nucleoside triphosphate concentrations in HIV-infected patients on dual nucleoside reverse transcriptase inhibitor therapy.
  Jeff D. Moore, Edward P. Acosta, Victoria A. Johnson, Roland L. Bassett, Joseph J. Eron, Margaret A. Fischl, Mary C. Long, Daniel R. Kuritzkes, Jean Pierre Sommadossi> ;Antiviral Therapy. 2007 Jan 1
• 129 citations
  Randomized controlled study of tenofovir and adefovir in chronic hepatitis B virus and HIV infection: ACTG A5127.
  Marion G. Peters, Janet Andersen, Patrick Lynch, Tun Liu, Beverly Alston-Smith, Carol L. Brosgart, Jeffrey M. Jacobson, Victoria A. Johnson, Richard B. Pollard, James ...> ;Hepatology. 2006 Nov 1
• Join now to see all